Association of ketamine with psychiatric symptoms andimplications forits therapeutic use and for understanding schizophrenia: A systematic review and meta-analysis
<strong>Importance</strong> Ketamine hydrochloride is increasingly used to treat depression and other psychiatric disorders but can induce schizophrenia-like or psychotomimetic symptoms. Despite this risk, the consistency and magnitude of symptoms induced by ketamine or what factors are...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
American Medical Association
2020
|